13 results
424B3
SCLX
Scilex Holding Company
2 Apr 24
Prospectus supplement
5:20pm
. During his tenure at CombiMatrix Corporation, Dr. Ji was responsible for strategic technology alliances with biopharmaceutical companies. From 1999 to 2001
POS AM
SCLX
Scilex Holding Company
27 Mar 24
Prospectus update (post-effective amendment)
5:30pm
, genetic analysis, molecular diagnostics and nanotechnology. During his tenure at CombiMatrix Corporation, Dr. Ji was responsible for strategic technology
424B3
SCLX
Scilex Holding Company
22 Sep 23
Prospectus supplement
5:32pm
in the areas of drug development, genetic analysis, molecular diagnostics and nanotechnology. During his tenure at CombiMatrix Corporation, Dr. Ji
424B3
SCLX
Scilex Holding Company
22 Sep 23
Prospectus supplement
5:31pm
technologies, including products and services in the areas of drug development, genetic analysis, molecular diagnostics and nanotechnology. During his tenure
424B3
9a7qk88fo
22 Sep 23
Prospectus supplement
5:27pm
424B3
10hco4ijmum3mo4879
22 Sep 23
Prospectus supplement
5:24pm
8-K
rznwj
22 Sep 23
Departure of Directors or Certain Officers
5:21pm
8-K
EX-3.1
y74z5 y0s
11 Jan 21
Vickers Vantage Corp. I Announces Pricing of Upsized $120,000,000 Initial Public Offering
4:02pm
424B4
u55ey1rjv
8 Jan 21
Prospectus supplement with pricing info
3:36pm
S-1
kbp8p1cvy o279n0c
15 Dec 20
IPO registration
2:50pm
S-1
EX-3.2
ubzsm8yv00dnfl402v
15 Dec 20
IPO registration
2:50pm
S-1
EX-3.1
qxmk02krf n92els
15 Dec 20
IPO registration
2:50pm
- Prev
- 1
- Next